Author

Gilles Mourier

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Amal KasriiD· 1 shared Béatrice SchaackiD· 1 shared Catherine MarqueriD· 1 shared Eleni GkanatsiouiD· 1 shared Erik PorteliusiD· 1 shared Gaëlle Fontaine· 1 shared Gunnar BrinkmalmiD· 1 shared Henrik ZetterbergiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Amal KasriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mutations in the juxtamembrane segment of the cholesterol-binding site of APP alter its processing and promotes production of shorter, less toxic Aβ peptides.

Linda Hanbouch, Béatrice Schaack, Amal Kasri, Gaëlle Fontaine, Eleni Gkanatsiou, Gunnar Brinkmalm, Erik Portelius, Kaj Blennow, Gilles Mourier, Nicolas Gilles, Mark John Millan, Catherine Marquer, Henrik Zetterberg, Lydie Boussicault, Marie‐Claude Potier

This study shows that mutations in the juxtamembrane cholesterol-binding site of APP reduce production of toxic Aβ40 and Aβ42 peptides and increase shorter, less toxic Aβ peptides.

bioRxiv · Nov 16, 2020 · PreprintNeuroscience